Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
LRMR · NASDAQ · Pharmaceutical Preparations
Larimar Therapeutics (LRMR) · oqro.io/stocks/LRMR · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$3.02+0.32 (+11.85%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
16 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
7 insiders in a week, a first since 2014Traded Nov 12 · filed 1 day later
Since the trade +11.8% · S&P 500 −0.4% · to Nov 13
A Larimar Therapeutics director paid $187K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month.
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
Since the trade +10.6% · S&P 500 −0.7% · to Nov 13
Larimar Therapeutics's President and COO paid $50K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
Since the trade +10.6% · S&P 500 −0.7% · to Nov 13
The CFO of Larimar Therapeutics paid $50K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
Since the trade +10.6% · S&P 500 −0.7% · to Nov 13
The CEO of Larimar Therapeutics paid $50K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
Since the trade +10.6% · S&P 500 −0.7% · to Nov 13
A Larimar Therapeutics director paid $9.8K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
Since the trade +10.6% · S&P 500 −0.7% · to Nov 13
A Larimar Therapeutics director paid $22K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in 9 months.
Insider buying
6 insiders in a week, a first since 2014Traded Nov 11 · filed 1 day later
Since the trade +10.6% · S&P 500 −0.7% · to Nov 13
Larimar Therapeutics's Chief Development Officer paid $14K out of pocket for Larimar Therapeutics shares. 6 other people at Larimar Therapeutics bought some too, in the same month. It was the first purchase in over a year.
Insider buying
Traded Jul 6 · filed 2 days later
Since the trade −8.2% · S&P 500 +0.4% · to Nov 13
A Larimar Therapeutics director paid $167K out of pocket for Larimar Therapeutics shares. Shares held went up 8% with this purchase.
Traded Feb 27, 2026 · largest single transaction ~$10M
Feb 27, 2026~$10M · 2M sh @ $5.00
DetailsOfficial recordInsider buying
4 insiders in a week, 2nd time since 2014Traded Feb 27 · filed 3 days later
Since the trade −43.1% · S&P 500 +10.0% · to Nov 13
A Larimar Therapeutics director paid $500K out of pocket for Larimar Therapeutics shares. 3 other people at Larimar Therapeutics bought some too, in the same month. Shares held went up 18% with this purchase.
Insider buying
4 insiders in a week, 2nd time since 2014Traded Feb 27 · filed 3 days later
Since the trade −43.1% · S&P 500 +10.0% · to Nov 13
A Larimar Therapeutics director paid $25K out of pocket for Larimar Therapeutics shares. 3 other people at Larimar Therapeutics bought some too, in the same month. Shares held went up 250% with this purchase.
Insider buying
4 insiders in a week, 2nd time since 2014Traded Feb 27 · filed 3 days later
Since the trade −43.1% · S&P 500 +10.0% · to Nov 13
A Larimar Therapeutics director paid $25K out of pocket for Larimar Therapeutics shares. 3 other people at Larimar Therapeutics bought some too, in the same month.
Traded Jul 31, 2025 · largest single transaction ~$10.8M
Jul 31, 2025~$10.8M · 3.39M sh @ $3.20
DetailsOfficial recordFeb 27, 2026~$5.42M · 1.08M sh @ $5.00
DetailsOfficial recordFeb 27, 2026~$5.42M · 1.08M sh @ $5.00
DetailsOfficial recordFeb 27, 2026~$4.16M · 832K sh @ $5.00
DetailsOfficial recordJul 31, 2025~$10.8M · 3.39M sh @ $3.20
DetailsOfficial recordJul 31, 2025~$8.32M · 2.6M sh @ $3.20
DetailsOfficial record15 open-market purchases and 0 open-market sales by insiders of LRMR between Feb 17, 2026 and today, placed against the company's last 4 earnings releases. The latest on file was filed Nov 9, 2026.
PurchaseSale30 days before a release30 days after
| Earnings release | 30 days before | On the day | 30 days after |
|---|---|---|---|
| Nov 9, 2026 | None | None | 7 purchases |
| Aug 4, 2026 | 1 purchase | None | None |
| May 14, 2026 | None | None | None |
| Mar 19, 2026 | 7 purchases | None | None |
Companies set trading windows, which usually close shortly before results and reopen after them, and insiders may trade under 10b5-1 plans adopted months earlier. A date alone does not show what a person knew or why they traded. Past release dates are the dates the company filed its 8-K with Item 2.02. An upcoming date, when one is mentioned, comes from the data provider's earnings calendar (Finnhub): it is not a company filing, it is not estimated by OQRO, and it may change. Open-market purchases and sales as reported on Form 4. Largest purchases around earnings, all companies